Bausch Health
BHC
#4840
Rank
C$2.97 B
Marketcap
C$7.96
Share price
0.35%
Change (1 day)
-14.54%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): C-$4.51

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is C-$4.53. In 2025 the company made an earnings per share (EPS) of C$0.59 an increase over its 2024 EPS that were of C-$0.17.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$4.51-867.43%
2025C$0.59-450%
2024C-$0.17-92.59%
2023C-$2.27160.89%
2022C-$0.87-76.64%
2021C-$3.7268.45%
2020C-$2.21-68.91%
2019C-$7.10-57.11%
2018C-$16.55-272.22%
2017C$9.61-199.29%
2016C-$9.68798.7%
2015C-$1.08-128.31%
2014C$3.81-204.62%
2013C-$3.64602.7%
2012C-$0.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
C-$0.38-91.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
C-$1.33-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA